Early career · publishing since 2020Rising activity
Hormonal Regulation and HypertensionEstrogen and related hormone effects14-3-3 protein interactionsProstate Cancer Treatment and ResearchGlioma Diagnosis and Treatment
Publications
27
Citations
23
Est. group size
~12
Recurring co-author estimate
Active years
7
Publishing since 2020
In context
Among 1,353 early career Medicine PIs within our index
Citations: 23p25 74 · p75 317 · cohort median 157
Publications / year (recent): 5.2p25 1.8 · p75 4.4 · cohort median 2.6
Typically publishes in teams of ~30 · 4% small-team papers (≤3 authors) · across 5 venues
Publication cadence
Publications per year over the last 10 years — averaging 5.2/year recently
Collaborators per year
Distinct co-authors at University of Michigan each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
Recent publications
- Abstract 3285: Itaconate acts as an oncometabolite to drive lethal pediatric ependymomas
Cancer Research · 2026
- Integration and Intersection of Cancer Metabolism with Epigenetic Pathways in Gliomas
Annual Review of Pathology Mechanisms of Disease · 2025
- Supplementary Data from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
2025
- Supplementary Information from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
2025
- Supplementary Information from β-catenin-driven differentiation is a tissue-specific epigenetic vulnerability in adrenal cancer
2024
- Supplementary Data from β-catenin-driven differentiation is a tissue-specific epigenetic vulnerability in adrenal cancer
2024
- Supplementary Information from β-catenin-driven differentiation is a tissue-specific epigenetic vulnerability in adrenal cancer
2024
- Supplementary Data from β-catenin-driven differentiation is a tissue-specific epigenetic vulnerability in adrenal cancer
2024
- Data from β-catenin-driven differentiation is a tissue-specific epigenetic vulnerability in adrenal cancer
2024
- PTEN Hemizygosity Drives Lower DNA Methylation, Immune Suppression, and Aggressive Behavior in IDH1-Mutant Astrocytomas
Deep Blue (University of Michigan) · 2024
- β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
Cancer Research · 2023
- Abstract 1501: Epigenetic dedifferentiation as a therapeutic strategy in adrenal cancer
Cancer Research · 2023
- Data from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
2023
- Supplementary Data from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
2023
- Data from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
2023
Publishes in
- Cancer Research×4
- Annual Review of Pathology Mechanisms of Disease×1
- Acta Neuropathologica×1
- bioRxiv (Cold Spring Harbor Laboratory)×1
- Deep Blue (University of Michigan)×1
Similar researchers
By research-topic overlap
- Donald W. Little
Medicine · University of Michigan
- Christopher R. LaPensee
Medicine · University of Michigan
- William E. Rainey
Medicine · University of Michigan
- Samuel W. Plaska
Medicine · University of Michigan
- Desmaré van Rooyen
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile